Literature DB >> 6656770

Species-specific inhibition by glycophorins of complement activation via the alternative pathway.

H Okada, H Tanaka.   

Abstract

Glycophorin, one of the major glycoproteins of erythrocytes (E), was extracted from human E (glycophorin-Hu) and guinea pig E (glycophorin-GP) and adsorbed to rabbit-E. The adsorption of glycophorin-Hu and glycophorin-GP to rabbit-E made the E resistant to hemolysis by human serum and guinea pig serum, respectively, via the alternative complement pathway (ACP). However, it did not make the rabbit-E resistant to hemolysis by serum heterologous to the glycophorin adsorbed. This species-specific inhibition by glycophorin of ACP activation should play a role in restricting ACP activation on self cell membranes. By recognizing the self-cell surface as the place where the complement reaction must be prevented, ACP will be able to accomplish the discrimination of non-self constituents without diversity of recognition sites for a variety of foreign substances.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6656770     DOI: 10.1016/0161-5890(83)90148-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Authors:  Imre Farkas; Lajos Baranyi; Yasushige Ishikawa; Noriko Okada; Csaba Bohata; Denes Budai; Atsuo Fukuda; Masaki Imai; Hidechika Okada
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

Review 2.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 3.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases.

Authors:  Denise V Tambourgi; Marcelo De Sousa Da Silva; Stephen J Billington; Rute M Gonçalves De Andrade; Fábio C Magnoli; J Glenn Songer; Carmen W Van Den Berg
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

5.  Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.

Authors:  M Endoh; M Yamashina; H Ohi; K Funahashi; T Ikuno; T Yasugi; J P Atkinson; H Okada
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

6.  Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.

Authors:  H Okada; N Wakamiya; N Okada; S Kato
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.

Authors:  C J Parker; T Wiedmer; P J Sims; W F Rosse
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

8.  Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells.

Authors:  L Baranyi; N Okada; K Baranji; H Takizawa; H Okada
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

9.  Tissue distribution of complement regulatory membrane proteins in rats.

Authors:  K Funabashi; N Okada; S Matsuo; T Yamamoto; B P Morgan; H Okada
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

10.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

Authors:  M E Medof; T Kinoshita; V Nussenzweig
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.